OpenEvidence vs Abridge: Revenue, Efficiency & Valuation
Compare OpenEvidence and Abridge on ARR per employee, revenue, headcount, valuation, funding, category rank, and source evidence.
Metric differences
OpenEvidence produces $1.5M ARR per employee versus $211K for Abridge, a directional gap of $1.3M per employee.
| Company | ARR/employee | ARR | Employees | Valuation | Funding |
|---|---|---|---|---|---|
| OpenEvidence | $1.5M | $150M | 99 | $12B | $250M Series D at $12B (Jan 2026) |
| Abridge | $211K | $100M | 473 | $5.3B | $316M Series E extension at $5.3B (Apr 2026) |
Company summaries
OpenEvidence
OpenEvidence is an AI platform providing evidence-based clinical decision support for physicians at the point of care. The system synthesizes medical literature, clinical guidelines, and real-world patient data to deliver real-time treatment recommendations tailored to specific patient scenarios. It is used by clinicians across specialties to quickly surface the most relevant research and consensus guidelines during consultations. OpenEvidence differentiates through its emphasis on cited, verifiable medical evidence rather than generalized AI outputs, making it a trusted resource for clinical decision-making at scale.
Abridge
Abridge is an AI-powered clinical documentation platform that automatically generates structured medical notes from patient-doctor conversations in real time. The platform is used by physicians, nurses, and other clinicians across major health systems to reduce the hours spent on documentation after patient visits. Abridge's models are trained specifically on medical dialogue, enabling high-accuracy capture of diagnoses, treatment plans, and follow-up instructions. The company has partnered with health systems including UPMC and Epic to integrate directly into EHR workflows, positioning itself as a core infrastructure layer for clinical AI.